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Synthesis and processing of the a heavy chains of secreted and
membrane-bound IgA
(murine B lymphoma/hybridoma/two-dimensional gel electrophoresis/ea chain mRNA/in vitro translation)
HITOSHI KIKUTANI*, ROBERTO SITIAt, ROBERT A. GOOD, AND JANET STAVNEZER
Sloan-Kettering Institute for Cancer Research, New York, New York 10021
Contributed by Robert A. Good, July 17, 1981
ABSTRACT We have compared the synthesis and processing
of immunoglobulin a chains in two murine cell lines, a B cell lym-
phoma that expresses membrane-bound IgA and a hybridoma that
secretes IgA. Results of biosynthetic labeling experiments dem-
onstrated that membrane-bound and secreted a chains have two
distinct intracellular precursors, of different molecular weights
and isoelectric points. RNAs from both of these cell lines direct
the synthesis in vitro of two a polypeptides of Mr 59,000 and
62,000, the larger one being the precursor for membrane-bound
a chain and the smaller one being the precursor for secreted a
chain. These cell lines each contain three RNAs, 1.7, 2.1, and 3.1
kilobases in length, which hybridize with cDNA for the a constant
region and which are present in different concentrations. Our
results suggest that the smallest RNA encodes the secreted a chain
and one or both of the larger RNAs encode(s) the membrane-
bound a chain.
Immunoglobulin (Ig) molecules have two major functions: to
serve as antigen receptors on the surface ofB lymphocytes and
to serve as effector antibodies after secretion from plasma cells.
Recently it has been shown that the kL polypeptide chains of
membrane-bound IgM have a hydrophobic domain at their
COOH terminus that is missing from the JA chains of secreted
IgM and that may play a role in the insertion of the A chains
into the lipid bilayer of the cellular membrane (1-5). B lym-
phocytes expressing IgM contain two different sized A mRNAs,
one ofwhich codes for membrane-bound ,u chain and the other
of which codes for secreted 1A chains (4-6).
To determine whether there are differences between the a
polypeptide chains of membrane-bound and secreted IgA, we
examined the synthesis and processing of a chains in two mu-
rine cell lines: a B lymphoma, BFO.3, expressing membrane-
bound IgA, and a hybridoma, ID150, secreting large amounts
of IgA. This report describes biosynthetic and in vitro trans-
lation studies which demonstrate that membrane-bound and
secreted IgA molecules contain different a polypeptide chains
that are encoded by different a mRNAs.
MATERIALS AND METHODS
Cell Lines. BFO.3, a cloned cell line expressing surface-as-
sociated IgA (a, A), was obtained by culturing 1.29 leukemic
tumor cells in vitro (7). The IgA-secreting hybridoma, ID150,
was obtained by hybridization of 1. 29 cells with P3-NS. 1-Ag-8
myeloma cells (8, 9). Both cell lines synthesize IgA and no other
class of Ig. These cells were maintained in RPMI 1640 medium
supplemented with 10% fetal calfserum, 2mM glutamine, pen-
icillin (100 unit/ml), and streptomycin (100 j.g/ml).
Cell Surface Labeling, Biosynthetic Labeling, and Immu-
noprecipitation. The cell surface was labeled either by lacto-
peroxidase (10) or with NaB3H4 and NaIO4 (11), using 5 mCi
of 125I or 0.5 mCi of NaB3H4, respectively, for 50 X 106 cells
(1 Ci = 3.7 x 1010 becquerels).
Cells were biosynthetically labeled by incubation at 37C in
a CO2 incubator in methionine-free RPMI 1640 medium con-
taining 10% dialyzed fetal calfserum and [35S]methionine (New
England Nuclear), or by incubation in glucose-free RPMI 1640
medium containing 10% dialyzed fetal calf serum and 3H-la-
beled sugar (New England Nuclear).
Lysis and immunoprecipitation by anti-a antiserum and
Staphylococcus aureus Cowan I strain were performed accord-
ing to Siden et aL (12), using either rabbit anti-mouse a chain
antiserum (Bionetics, Kensington MD) or affinity-purified goat
anti-mouse a chain antibody made against IgA from MOPC 460
(gift from P. Kincade). The material immunoprecipitated by
both antibodies was identical as analyzed by NaDodSO4/gel
electrophoresis.
NaDodSO4/Polyacrylamide Gel Electrophoresis and Two-
Dimensional (2D) Gel Electrophoresis. Immunoprecipitates
were analyzed by electrophoresis in 10% polyacrylamide slab
gels containing NaDodSO4 (13) or by a combination of isoelec-
tric focusing and electrophoresis on 2D gels (14). '4C-Labeled
proteins (Bethesda Research Laboratories, Rockville MD) were
used as molecular weight markers. After electrophoresis, gels
were treated with 2,5-diphenyloxazole (15), dried, and exposed
to Kodak XR film at -800C.
Isolation of RNA, RNA Blotting, and In Vitro Translation.
RNA was isolated from cytoplasmic fractions thatwere prepared
from ID150 and from BFO.3 cells by lysing them in a Dounce
homogenizer in 0.5% Nonidet P40/10mM Tris HCl (pH 7.4)/
140 mM NaCl/1.5 mM MgCl2, followed by centrifugation at
650 x g for 10 min to pellet the nuclei. The cellular homoge-
nates appeared to contain intact nuclei and a small fraction of
whole cells by examination in the light microscope. The cyto-
plasm was adjusted to 10 mM ribonucleoside-vanadyl com-
plexes (16)/10mM Na2EDTA (pH 7.0)/0.5% NaDodSO4. RNA
was extracted with phenol/chloroform. Poly(A)+ RNA was iso-
lated by two successive adsorptions to oligo(dT)-cellulose. To
determine the size of the a chain RNAs, RNA was denatured
with dimethyl sulfoxide and glyoxal, fractionated by electro-
phoresis on 1% agarose gels in 10mM phosphate at pH 7.0 (17),
and blotted (18) to diazophenyl-thioether paper, which was pre-
pared according to B. Seed (see footnote 51 in ref. 18). The RNA
blots were hybridized as described (19) and then washed in
0.1x SSPE (1x SSPE = 0.15 M NaCl/1 mM Na2EDTA/10
Abbreviations: 2D, two-dimensional; kb, kilobase(s); am, membrane-
bound a chain; a,, secreted a chain.
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mM sodium phosphate, pH 6.8) at 52TC. The probe was a nick-
translated DNA fragment containing the a constant region se-
quence, which was isolated from the cDNA plasmid pa(J558)13
(20) (given by K. B. Marcu, State University of New York at
Stony Brook) by digestion with Msp I restriction endonuclease.
In vitro translation of cytoplasmic RNA was performed in the
rabbit reticulocyte system (Bethesda Research Laboratories)
(21).
RESULTS
Biosynthetic Labeling of BFO.3 and ID150 Cells. The B
lymphoma cell line, BFO.3, expresses membrane-bound IgA
but secretes very little IgA (ref. 7; unpublished data). The hy-
bridoma line, ID150, secretes large amounts of IgA (8) but ex-
presses little or no membrane-bound IgA (unpublished data).
The a heavy chains synthesized by both cell lines have the same
idiotype (1.29 idiotype) (refs. 7 and 8; unpublished data).
To compare the IgA molecules synthesized by BFO.3 and
ID150, the cells were incubated for 6 hr in medium containing[NS]methionine and lysed with detergent buffer, and the IgA
was immunoprecipitated with anti-a chain antiserum. The bio-
synthetically labeled IgA molecules were analyzed by 2D gel
electrophoresis. As shown in Fig. 1A, lysates of BFO.3 cells
contained two spots, a and a', a cluster of small spots, b, and
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FIG. 1. 2D gel analysis of IgA molecules of BFO.3 and ID150 cells.
Lysates or culture supernatants of radiolabeled cells were immuno-
precipitated with anti-a chain antiserum. (A) Lysate of BFO.3 cells
labeled with [36S]methionine for 6 hr; (B) lysate of ID150 cells labeled
with [35S]methionine for 6 hr; (C) culture supernatant of 1D150 cells
labeled with [35S]methionine for 6 hr; (D) lysate of radioiodinated
BFO.3 cells; (E) lysate of BFO.3 cells labeled with NaB3H4. All gels
are shown with the acidic side on the right and decreasingMr from top
to bottom. An apparent Mr of each spot was calculated from the mi-
gration of labeled marker proteins that were electrophoresed on the
second dimension of the same or a parallel gel. L, light chain; IEF, iso-
electric focusing.
a more acidic spot, c, of higher molecular weight, all in the
position of serum a chain (Mr 61,000-67,000). BFO.3 cells also
had one A chain (ref. 7; unpublished data), migrating with an
apparent Mr of 23,000. By contrast, intracellular IgA from the
lysate of ID150 cells showed two a spots, which correspond to
a and a' of BFO.3, and an additional light chain spot, which
migrated with an apparent Mr of 25,000 (Fig. 1B). This light
chain is presumably a K chain contributed by the NS. 1 myeloma
(8, 22).
IgA was immunoprecipitated from the medium in which the
ID150 cells had been labeled and was analyzed on a 2D gel. In
addition to the spots observed in the lysate of ID150 cells, a
smear of spots extending from a' in the acidic direction and an
acidic spot, d, with an apparent Mr of 23,000 were observed
(Fig. 1C). Spot d probably corresponds to the J chain, which
is associated with secreted IgA and which migrates similarly to
the immunoglobulin light chain on NaDodSO4/polyacryla-
mide gels (23, 24). It was also detected in the lysates of ID150
cells upon longer exposure of the film (data not shown). Spot
d was not detected in BFO.3 cells.
Identification of Membrane-Bound a Chains (am) by Cell
Surface Labeling. To determine which spots represent am, the
surface of BFO.3 cells was labeled by radioiodination to label
the tyrosine residues (10), and with NaB3H4 and NaIO4 to label
the sialic acid residues (11) (Fig. 1 D and E, respectively).
BFO.3 cells labeled by both methods showed only one a chain
spot, which corresponded to spot c of internally labeled BFO.3
cells, indicating that the most acidic a chain (spot c) was am.
Lysates of biosynthetically labeled ID150 cells did not show
any spot that corresponded to am (Fig. 1B), and little or no am
could be detected by radioiodination or by immunofluores-
cence (unpublished results). Therefore, it appears that spots a
and a' may be intracellular precursors for secreted a chain (as)
and that these a chains become more acidic shortly before or
during secretion.
Pulse-Chase Labeling of BFO.3 Cells. BFO.3 cells contain
am (spot c) and also intracellular precursor(s) for a, (spots a, a',
or both). There are two possibilities for the cluster ofsmall spots,
b, found in the lysates of BFO.3 but not of ID150 cells (Fig. 1
A and B). (i) Cluster b may represent intracellular precursors
for am. (ii) Cluster b may represent intermediates in the pro-
cessing of a5-i.e., more acidic forms of the same polypeptide
chain(s) as in spots a and a'. If the conversion of these putative
intermediates to mature as were more rapid in ID150 than in
BFO.3 cells, it is possible that they might not be detected in
lysates of ID150 cells labeled for 6 hr (due to the large size of
spots a and a').
To distinguish these possibilities and to analyze the turnover
of a chains in BFO. 3 cells, pulse-chase experiments were per-
formed. BFO.3 cells were labeled for 10min with [3S]methionine
and chased for various times. As shown in Fig. 2A, BFO.3 cells
labeled for 10 min had spots a, a', and a very intense spot(s) b,
but did not have spot c. After a 45-min chase, spot c appeared
(Fig. 2B). As the duration of the chase increased, spot(s) b be-
came progressively fainter (Fig. 2 C-F), almost disappearing by
6 hr (Fig. 2E). Spot(s) b could not be detected after a 24-hr chase
(Fig. 2F). Spot c was still quite dark at 6 hr, but very faint after
a 24-hr chase. These results suggest that spot(s) b represents
an intracellular precursor for am (spot c) and that these proteins
are rapidly turned over and shed from the membrane. Spots a
and a' persisted 24 hr after the chase (although they became less
intense), indicating that spots a and a' are not precursors for
spots b and c, and they have a very slow turnover in BFO.3 cells.
Sugar Labeling ofBFO.3 and ID150 Cells. Our results sug-
gest that there are different intracellular precursors for as and
am and that these a chains increase in size and become more
Immunology: Kikutani et aL
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FIG. 2. 2D gel analysis of pulse-chase-labeled a chains. Cells (20
x 10) were labeled for 10 min with [9Slmethionine, washed, and di-
vided into six portions. Each portion was chased for 0 min (A), 45 min
(B), 90 min (C), 3 hr (D), 6 hr (E), or 24 hr (F) in nonradioactive medium.
After the chase, cells were lysed, and IgA was immunoprecipitated
with anti-a chain antiserum.
acidic during their maturation. To determine whether glyco-
sylation is involved in the processing of the a chains, BFO.3
and ID150 cells were labeled for 6 hr with three different sug-
ars, either with [3H]mannose to label the core sugars or with
[3H]fucose or [3H]galactose to label the terminal sugars (25). As
shown in Fig. 3, it appears that in both ID150 and BFO.3 cells
mannose was mostly incorporated into the same spot (a) that was
pulse-labeled by methionine. By contrast, fucose and particu-
larly galactose were incorporated to a greater extent into the
most acidic spots. Because the patterns obtained by labeling
with fucose differed from those obtained by labeling with ga-
lactose (galactose being incorporated into the more acidic mol-
ecules), the heterogeneity ofthe pI and molecular weight ofthe
a chains may reflect the kinds and amounts of added sugars.
mRNA for a Chains ofBFO.3 and ID150 Cells. Biosynthetic
labeling experiments suggest that there are two distinct pre-
cursors for am and as. To provide further evidence for the ex-
istence of two different a polypeptides, we attempted to de-
termine whether these cells contained more than one a chain
mRNA. Cytoplasmic RNA from BFO.3 and ID150 cells was
analyzed by gel electrophoresis, blotting to diazotized paper,
and hybridization with a cloned cDNA, pa(J558) 3, coding for
the a constant region (20). Three species ofpoly(A)+ RNAs, 1.7,
2.1, and 3.1 kilobases (kb) in length, were detected in BFO.3
cells (Fig. 4). Poly(A)+ RNA from ID150 cells also contained
these same species, although the amount ofthe 1.7-kb RNA was
much greater in ID150 than in BFO.3 cells. (In Fig. 4 it appears
that the 1.7- and 2.1-kb a RNAs are larger in ID150 than in
BFO.3 cells, but this may be due to a gel artifact caused by the
large amount of the 1.7-kb RNA in the ID150 lane.)
The 1.7-kb a RNA probably encodes as because the relative
amounts ofthe 1.7-kb RNA in ID150 and BFO.3 cells correlate
well with the relative abundance of secreted IgA in these two
cell lines. Furthermore, the size of a mRNA in myeloma cells
is also 1.7kb (unpublished data). Either or both ofthe two larger
RNAs that hybridize with pa(J558)13 probably encode am.
FIG. 3. 2D gel analysis of intracellular a chains of BFO.3 and
1D150 cells incubated with 3H-labeled sugars. Cells were incubated for
6 hr with 3H-labeled sugars and lysed, and a chains were immuno-
precipitated. (A-C) BFO.3 cells labeled with [(3H~annose (A), PHlficose
(B), [3Hlgalactose (C). (D-F) 1D150 labeled with [3H]mannose (D),
[3H]fucose (E), or [3Hlgalactose (F).
In Vitro Translation of RNA from BFO.3 and ID150 Cells.
To determine whether the a RNAs detected by hybridization
with pa(J558)'3 can actually function as mRNAs for a chain,
cto 0C:
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FIG. 4. Ig a chain sequences in cytoplasmic RNA from BFO.3 and
1ID150 cells. Poly(A)+ RNAs from BFO.3 (3 yg) and from ED150 (2 pg),
and Hindfl fragments of A bactenophage DNA (labeled with 32P by
polynucleotide kinase) were denatured with dimethyl sulfoxide/
glyoxal, fractionated by electrophoresis in an agarose gel, and blotted
to diazotized paper. The blotwas hybridized with a 3P-labeled acDNA
probe and exposed for 4 hr at -80'C to XR film, using an enhancing
screen. The sizes in kb of the a RNAs present in BFO.3 cells (indicated
on the right) were determined relative to the sizes ofHinduH fiagments
of A DNA, which are indicated on the left.
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FIG. 5. In vitro translation of RNA from BFO.3 and 1ID150 cells.
a chains synthesized in vitro or labeled in vivo with [35S]methionine
for 6 hr either in the presence of tunicamycin (2.5 pAg/ml) (after a 2-
hr preincubation with tunicamycin) or in the absence of tunicamycin
were immunoprecipitated and analyzed on a NaDodSO4/polyacryl-
amide gel. Tunicamycin inhibited mannose incorporation into IgA by
92%. In vitro translation of total cytoplasmic RNA from BFO.3 and
from ID150 cells was performed in a rabbit reticulocyte system. Lanes:
a, lysate from BFO.3 cells labeled in the presence of tunicamycin; b,
lysate from BFO.3 labeled in the absence of tunicamycin; c, lysate from
ID150 (with tunicamycin); d, lysate from ID150 (without tunicamycin);
e, cell-free translation product of total cytoplasmic RNA from BFO.3
(40 pg); f, cell-free translation product of total cytoplasmic RNA from
ID150 (8 pg); a', 3-fold longer exposure of a; e', 5-fold longer exposure
of e; f', 5-fold longer exposure of The leftmost lane shows marker
proteins, with Mr x 10 .
cytoplasmic RNAs from BFO.3 and IDS50 cells were translated
in vitro. Two a polypeptides (Mr 59,000 and 62,000), in ap-
proximately equal amounts, were obtained by the in vitro trans-
lation of RNA from BFO.3 cells (Fig. 5, lane e). By contrast,
one a polypeptide chain (Mr 59,000) was the predominant trans-
lation product o6fRNA from IDl50 cells (Fig. 5, lane f), although
a very faint larger a chain (Mr 62,000) was detected when the
gel was exposed to film five times longer (lane f'). Because
ID150 cells synthesize predominantly secreted IgA, it appears
likely that the Mr 59,000 chain is the polypeptide precursor for
a., and the Mr 62,000 polypeptide is the precursor for am.
The sizes of the a chains synthesized in vitro were compared
with the sizes of a chains synthesized in vivo in the presence
and absence oftunicamycin (Fig. 5, lanes a-d, a'). Tunicamycin
inhibits N-linked glycosylation (26, 27). The a chains synthe-
sized in vitro were smaller than the a chains synthesized in vivo
in the absence of tunicamycin (BFO.3, lane b; ID150, lane d)
but larger than the a chains synthesized in tunicamycin-treated
cells (BFO.3, lanes a, a'; ID150, lane c), probably because the
a chains synthesized in vitro are not glycosylated but do retain
the NH2-terminal signal peptides (28, 29). The largest band.in
lane b probably corresponds to spot c in Fig. IA and the smaller
one may correspond to spots a, a', and b. The band in lane d
probably corresponds to spots a and a' in Fig. lB.
The amount ofam synthesized in BFO.3 cells in the presence
of tunicamycin appeared to be much less than that obtained by
in vitro translation. It is possible that this result was observed
because am turns over more rapidly than does as in BFO.3 cells,
and during the 6-hr labeling period the pool of [3S]methionine
was exhausted.
DISCUSSION
Two Distinct Precursors for a Chain. Our data demonstrate
that two distinct polypeptides serve as precursors for am and
as. Evidence supporting this conclusion was provided by com-
paring the a chains synthesized in the B lymphoma, BFO.3,
which expresses membrane-bound IgA and secretes very little
IgA, and the hybridoma, ID150, which secretes large amounts
of IgA but bears little or no membrane-bound IgA. These cell
lines were derived from the same leukemic tumor and syn-
thesize IgA of the identical idiotype.
The polypeptides obtained by in vitro translation of cyto-
plasmic RNAs from these two cell lines differed in size. RNA
from ID150 cells directed predominantly the synthesis of a Mr
59,000 a polypeptide, whereas translation ofRNA from BFO.3
cells yielded a Mr 59,000 a polypeptide but, in addition, ap-
proximately equal amounts of a Mr 62,000 a polypeptide. From
the relative amounts ofthe Mr 59,000 and 62,000 a polypeptides
obtained, it appears that the Mr 59,000 polypeptide is the pre-
cursor for as, and the Mr 62,000 polypeptide is the precursor
for am.
The kinetics of biosynthetic labeling ofthe a chains in BFO.3
cells also supported the presence of two distinct precursors for
am and as, because the rates of turnover of these precursors
were inconsistent with the existence of a single precursor for
both am and as. These results are in agreement with reports by
others that 1 and 'y2a chains of membrane-bound and secreted
IgM and IgG2a, respectively, contain different polypeptide
chains (2-6, 30, 31).
Differential Turnover ofa Chains in Viva BFO.3 cells syn-
thesize approximately equal amounts of the two polypeptide
precursors for am and as (Fig. 2A and Fig. 5, lane e), although
BFO.3 cells secrete very little IgA into the medium (ref. 7;
unpublished data). The results of the pulse-chase experiments
showed that the polypeptide precursor for as is turned over very
slowly in BFO.3 cells (Fig. 2). Furthermore, BFO.3 cells con-
tain cytoplasmic granules or vesicles, which intensely fluoresce
when fixed cells are stained with anti-a conjugated to rhoda-
mine (7). These granules or vesicles may sequester the precur-
sor(s) for secreted IgA. A lack of glycosylation is probably not
the explanation for why these a chains are not secreted, because
tunicamycin does not inhibit the secretion of IgA from ID150
cells (data not shown). The half-life ofthe a chains in IDiS0 cells
is less than 2 hr and therefore the turnover of as is much more
rapid in ID150 than in BFO.3 cells (data not shown).
ID150 cells also contain mRNAs that can be translated in
vitro to yield the polypeptide precursors for as and am (although
they do have much more of the mRNA coding for as). However,
biosynthetic labeling of ID150 for 6 hr failed to show any spot
corresponding to am (Fig. 1B). To attempt to detect the syn-
thesis of the precursor for am in ID150 cells, the a chains of
ID150 cells were labeled by a 5-min pulse with [3S]methionine
and then analyzed on a 2D gel. A cluster of spots resembling
the b spot(s) of BFO.3 cells was detected (data not shown), but
the fate of these spots could not be followed during the chase
period, because as were so much more predominant and thus
obscured spot(s) b. It seems likely that a small amount of the
precursor(s) for am is synthesized in ID150 cells, and either it
is rapidly turned over or the amount of membrane-bound IgA
present on ID150 cells is so small relative to the amount of se-
creted IgA that it could not be detected.
Processing of the a Polypeptide Chains. Sugar labeling ex-
periments indicated that the heterogeneity of the a chain was
correlated with the presence of different kinds and amounts of
sugars. Furthermore, when [3S]methionine-labeled lysates of
BFO.3 and ofID150 cells and the culture supernatant ofID150
were treated with sialidase, the acidic spots (c and the smear
corresponding to as) shifted toward the basic direction (data not
shown); when tunicamycin was present during biosynthetic la-
beling with [3S]methionine, the acidic spots corresponding to
the mature forms of as and am disappeared (data not shown).
These results indicate that glycosylation is involved in the pro-
cessing ofprecursor molecules for am and a,. It is unknown why
fucose, which is believed to be a terminal sugar, is incorporated
into the precursor molecule (spot a) as well as into the more
Immunology: Kikutani et al
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acidic a chains, although Sidman (32) reported that fucose la-
bled the intracellular precursor of p. chain similarly to mannose.
Three a RNAs. Membrane-bound and secreted p. chains are
encoded by two different mRNAs (2.7 and 2.4 kb), which differ
in sequence at their 3' ends (4-6). BFO.3 cells contain ap-
proximately equal amounts of three RNAs that hybridize with
the a probe, 1.7, 2.1, and 3.1 kb in length, whereas ID150 cells
contain relatively much more of the 1.7-kb a RNA but do also
contain the two larger RNAs. Only two a polypeptides appeared
to be obtained by in vitro translation ofRNA from BFO.3 cells.
It is possible that one of the larger a RNAs is not a functional
mRNA 6r that the two larger a RNAs encode the same size
polypeptide chain, or, perhaps, the identical polypeptide chain.
It does not appear likely that one of the two larger a RNAs is
an incompletely processed nuclear RNA that has leaked into the
cytoplasmic fraction, because the amounts of these two larger
RNAs are comparable to the amount of 1.7-kb RNA in BFO.3
cells. Furthermore, when a sequences present in total cell or
nuclear RNAs from BFO.3 and ID150 cells were examined on
RNA blots, the nuclear species larger than 3.1 kb were present
in much lower amounts than were any of the three cytoplasmic
a RNAs, and the amounts ofthe three cytoplasmic a RNAs rel-
ative to each other were the same as in the cytoplasm (data not
shown).
Transcription of the a RNAs. Early et al (33) reported that
the two different mRNAs for A. chains were transcribed from
the same pu gene and were produced either by differential ter-
mination of transcription, or by alternative splicing of a single
RNA transcript. It appears likely that the three a RNAs are also
transcribed from one a gene, because Southern blots of geno-
mic DNAs from BFO.3 and ID150 cells indicate that these cells
contain one rearranged a gene with the identical restriction
map in both cell lines (unpublished-data). Because the relative
amounts ofthe three a RNAs differ between the lymphoma and
hybridoma cells, mechanisms to regulate the termination of
transcription or the preferential use ofcertain splice sites in the
a RNA transcript(s) must exist.
Note Added in Proof. The three RNAs detected in BFO.3 and ID150
cells are transcribed from the expressed a gene. This statement is sup-
ported by the facts that (i) BFO.3 cells contain two heavy chain chro-
mosomes, one ofwhich contains a rearranged a gene and one ofwhich
retains the a gene in the germline configuration, and (ii) each of the
three RNAs detected with the a cDNA probe also hybridizes with a
genomic DNA probe for theJH3 andJH4 gene segments. By translation
ofRNA fractionated on a sucrose gradient, we have determined that the
largest a RNA (3. 1-kb) codes for am (unpublished).
We are grateful to Dr. K. Marcu for pa(J558) 3, to Drs. L. Hood, K.
0. Lloyd, Y. S. Choi, P. Ralph, and U. Hammerling for their critical
reading of the manuscript, and to Mrs. J. Kikutani and Mrs. S. Sirlin
for their excellent technical assistance. This work was supported by
grants from the National Institutes of Health (Al GM14617, BRSG
507RR05534, AI-11843, NS11457, and AG 00541), North Atlantic
Treaty Organization (RG 186-80), The March of Dimes-Birth Defects
Foundation (5-255), The Zelda Radow Weintroub Cancer Fund, The
Richard Molin Memorial Foundation, The J.M. Foundation, and The
Joe Brooks Research Fund for Advanced Study of Cancer.
1. Williams, P. B., Kubo, R. T. & Grey, H. M. (1978) J. Immunot
121, 2435-2439.
2. Kehry, M., Ewald, S., Douglas, R., Sibley, C., Raschke, W.,
Fambrough, D. & Hood, L. (1980) Cell 21, 393-406.
3. McCune, J. M., Lingappa, V. R., Fu, S. M., Blobel, G. & Kun-
kel, H. G. (1980)J. Exp. Med. 152, 453-468.
4. Singer, P. A., Singer, H. H. & Williamson, A. R. (1980) Nature
(London) 285, 294-300.
5. Rogers, J., Early, P., Carter, C., Calame, K., Bond, M., Hood,
L. & Wall, R. (1980) Cell 20, 303-312.
6. Alt, F. W., Bothwell, A. L. M., Knapp, M., Siden, E., Mather,
E., Koshland, M. & Baltimore, D. (1980) Cell 20, 293-301.
7. Sitia, R., Rubartelli, A. & Hammerling U., J. ImmunoL, in press.
8. Tada, N. & HAmmerling, U. (1980) Immunogenetics 11, 7-19.
9. Tada, N., Kimura, S., Binari, R., Lui, Y. & Hammerling, U.
(1980) Immunogenetics, in press.
10. Marchalonis, J. J. (1969) Biochem. J. 113, 299-305.
11. Lloyd, K. O., Travassos, L. R., Takahashi, T. & Old, L. J. (1979)
J. Nati Cancer Inst. 63, 623-634.
12. Siden, E. J., Baltimore, D., Clark, D. & Rosenberg, N. E. (1979)
Cell 16, 389-396.
13. Laemmli, U. K. (1970) Nature (London) 227, 680-685.
14. O'Farrell, P. H. (1975) J. Biol Chem. 250, 4007-4021.
15. Bonner, W. M. & Laskey, R. A. (1974) Eur. J. Biochem. 46,
83-88.
16. Berger, S. L. & Birkenmeier, C. S. (1979) Biochemistry 18,
5143-5149.
17. McMaster, G. K. & Carmichael, G. G. (1977) Proc. Nati Acad.
Sci. USA 74, 4835-4838.
18. Alwine, J. C., Kemp, D. J., Parker, B. A., Reiser, J., Renart, J.,
Stark, G. R. & Wahl, G. M. (1980) Methods Enzymol 68,
220-242.
19. Cayre, Y., Palladino, M. A., Marcu, K. B. & Stavnezer, J. (1981)
Proc. Natl Acad. Sci. USA 78, 3814-3818.
20. Marcu, K. B., Banerji, J., Penncavage, N. A., Lang, R. &
Arnheim, N. (1980) Cell 22, 187-196.
21. Pelham, H. R. B. & Jackson, R. J. (1976) Eur. J. Biochem. 67,
247-256.
22. Kohler, G., Howe, S. C. & Milstein, C. (1976) Eur. J. Immunol
6, 292-295.
23. Wilde, C. E., III & Koshland, M. E. (1973) Biochemistry 12,
3218-3224.
24. Koshland, M. E. (1975) Adv. Immunot 20, 41-69.
25. Melchers, F. & Andersson, J. (1973) Transplant. Rev. 14, 76-130.
26. Takatsuki, A., Arima, K. & Tamura, G. (1971) Agric. Biol Chem.
39, 2098-2091.
27. Lehle, L. & Tanner, W. (1976) FEBS Lett. 71, 167-170.
28. Milstein, C., Brownlee, G. G., Harrison, T. M. & Mathews, M.
B. (1972) Nature (London) 239, 117-120.
29. Blobel, G. & Dobberstein, B. (1975)J. Cell Biol. 67, 835-851.
30. Sibley, C. H., Ewald, S. J., Kehry, M. R., Douglas, R. H.,
Raschke, W. C. & Hood, L. E. (1980) J. Immunol 125,
2097-2105.
31. Oi, V. T., Bryan, V. M., Herzenberg, L. A. & Herzenberg, L.
A. (1980) J. Exp. Med. 151, 1260-1274.
32. Sidman, C. (1981) Cell 23, 379-389.
33. Early, P., Rogers, J., Davis, M., Calame, K., Bond, M., Wall,
R. & Hood, L. (1980) Cell 20,313-319.
Proc. Nad Acad. Sci. USA 78 (1981)
